LILLIAN MORTON: Open Payments
NPI 1114331527 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 34 payments from 18 companies in 2025. Trend: 2023 $132 · 2024 $1,288 · 2025 $961
Food & beverage: $861Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $190 |
| AstraZeneca Pharmaceuticals LP | 6 | $141 |
| Janssen Biotech, Inc. | 3 | $81 |
| SI-BONE, INC. | 1 | $72 |
| Daiichi Sankyo Inc. | 2 | $51 |
| SOBI, INC | 1 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $40 |
| BeOne Medicines USA, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
Products named: TALVEY, JAKAFI, IMFINZI, ENHERTU, Doptelet, ICLUSIG, BRUKINSA, LIBTAYO.
Industry payments across NV — which companies pay providers there.
